Conjoint analysis and choice models
Can you justify the cost of continuing to develop a new compound? We can answer that fundamental question.
You'll also want to know how sensitive your target (or most likely) profile is to any surprises that might emerge from clinical trials.
Choice models determine the market potential for a compound in development.
You also learn how the use of that product can be expected to change if the profile changes. And which profile changes have the greatest potential to improve or hurt that use.
Best of all, once you have completed a choice (or conjoint) study, you get a Market Simulator that continues to evaluate the potential use of your compound when new profile or market data becomes available.
We're ready to show you which choice (or conjoint) model will best meet your needs.